Yuval Sufaro

Yuval Sufaro

Auto-generated profile, based on publicly available information

Yuval Sufaro

Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2009 in Resuscitation
Verified
Journal Article
Closed access
GSGad Shaked
Gad Shaked
GGGeorge Grinberg
George Grinberg
YSYuval Sufaro
Yuval Sufaro
ADAmos Douvdevani
Amos Douvdevani
YSYoram Shapira
Yoram Shapira
DCDavid Czeiger
David Czeiger

11 April 2018 in Journal of Clinical Neuroscience
Verified
Journal Article
Closed access
PDF file
AAAmit Azriel
Amit Azriel
BFBenjamin Fleming
Benjamin Fleming
UDUri P. Dior
Uri P. Dior
SMSamuel Moscovici
Samuel Moscovici
YSYuval Sufaro
Yuval Sufaro
KDKate Drummond
Kate Drummond

4 November 2026 in Acta Neurochirurgica
Verified
Journal Article
Open access
PDF file
AMAya Mudrik
Aya Mudrik
AAAmit Azriel
Amit Azriel
MOMai Ofri
Mai Ofri
NPNave Paran
Nave Paran
EAElad Avraham
Elad Avraham
YSYuval Sufaro
Yuval Sufaro
Purpose: To identify demographic and clinical risk factors associated with developing new mental-health diagnoses within one year after mild traumatic brain injury (mTBI) in young adults. Methods: This retrospective cohort study used linked hospital and community electronic health records from a tertiary district referral hospital and an integrated payer-provider organization. Adults aged 18–45 years presenting with mTBI (Glasgow Coma Scale score 14–15) between 2000 and 2020 were included. Patients admitted to the intensive care unit or lacking continuous follow-up were excluded. Univariable analyses compared demographic, clinical, and psychiatric characteristics between individuals with and without new mental-health diagnoses (defined using ICD-9 codes). Multivariable logistic regression with generalized estimating equations was used to estimate adjusted odds ratios (ORs) for independent risk factors. Secondary outcomes included 12-month emergency-department visits, hospitalizations, and inpatient days. Results: A total of 9,835 mTBI events among 8,985 unique patients were analyzed. Within one year of injury, 538 events (5.5%) were followed by a new mental-health diagnosis. Patients with new diagnoses were older, more likely to have a prior TBI (56% vs 19%; p = 0.010), and more frequently hospitalized from the emergency department (22% vs 9.9%; p < 0.001). In multivariable analysis, risk was independently associated with prior TBI (one prior injury OR 3.90, 95% CI 2.96–5.14; ≥ 2 injuries OR 6.37, 95% CI 5.00–8.12), hospitalization at the index visit (OR 1.79, 95% CI 1.18–2.71), and pre-existing mental-health history (OR 1.84, 95% CI 1.49–2.28). Conclusion: Young adults with previous TBI, prior psychiatric history, or hospitalization after mTBI are at increased risk for developing new mental-health disorders. Early identification of these high-risk subgroups could guide structured follow-up and preventive mental-health interventions to reduce the long-term psychosocial burden of mTBI.

21 July 2026 in European Journal of Endocrinology
Verified
Journal Article
Closed access
KKKeren Kaminer
Keren Kaminer
ISIlan Shimon
Ilan Shimon
YRYaron Rudman
Yaron Rudman
TDTalia Diker-Cohen
Talia Diker-Cohen
SKShiri Kushnir
Shiri Kushnir
Amit AkirovAmit Akirov
Amit Akirov
Objective: Cushing syndrome (CS) is associated with depression and anxiety. This study compared treated mood and anxiety disorders between patients with CS and controls, assessing differences by etiology and remission status. Methods: A retrospective matched-cohort study of patients with endogenous CS (2000-2024) from the Clalit Health Services database. Each patient was matched with 5 controls by age, sex, socioeconomic status, and BMI. Mood and anxiety disorders were identified through affective drug dispensations (ADD). Drug discontinuation was defined as ≥1 month without dispensations. Results: The cohort included 540 patients with CS (mean age 47.79 ± 17.01 years; 64.44% women) and 2517 controls, with a median follow-up of 13.20 years (IQR 8.41-18.42). At baseline, patients with CS had nearly twice the odds of receiving ADD than controls (OR = 1.93, 95% CI,1.39-2.66), with a significant excess in women (12.93% vs. 6.93%, OR = 1.99, 95% CI, 1.38-2.87). During the entire follow-up, drug discontinuation rates did not differ (HR = 0.72, 95% CI, 0.50-1.04), whereas the risk of new-onset ADD was 2-fold higher in CS (HR = 2.23, 95% CI, 1.89-2.62). This increased risk was observed in both Cushing disease (HR = 2.44, 95% CI, 1.90-3.13) and adrenal CS (HR = 2.17, 95% CI, 1.64-2.88). Using a 2-year landmark analysis initiated 2 years after diagnosis, the increased risk persisted in patients who achieved remission (HR = 2.10, 95% CI, 1.59-2.78) and in those who did not (HR = 2.38, 95% CI, 1.60-3.55). Conclusion: Endogenous CS is associated with a persistently increased risk of treated affective disorders at diagnosis and throughout long-term follow-up, underscoring the need for ongoing psychological care.